Showing 4,841 - 4,860 results of 8,129 for search 'Deraj~', query time: 2.36s Refine Results
  1. 4841

    Role of biosimilar introduction on insulin glargine prices: a retrospective analysis in 28 European countries by David Beran, Margaret Ewen, Mario Raviglione, Tido von Schoen-Angerer, Davide Morolla

    Published 2025-01-01
    “…Segmented regression analysis using a dual-model approach: pooled and country-specific.Setting 28 European countries using data from the European Medicine Price Database for the period 2013–2023.Main outcome measures Price variations between countries were analysed to assess trends and correlations before and after biosimilar market entry.Results In the 28 countries studied, cost of insulin glargine underwent a median 21.6% decrease overall in the last decade (p<0.001). In 2022, the median price was €9.0 for the originator (first to market) Lantus (IQR €8.1–€10.4), €8.9 for the biosimilar Abasaglar (IQR €7.6–€10.1) and €7.0 for the biosimilar Semglee (median €7.0; IQR €6.8–€7.5). …”
    Get full text
    Article
  2. 4842
  3. 4843
  4. 4844
  5. 4845
  6. 4846
  7. 4847
  8. 4848
  9. 4849
  10. 4850
  11. 4851
  12. 4852
  13. 4853
  14. 4854
  15. 4855
  16. 4856
  17. 4857
  18. 4858
  19. 4859
  20. 4860